This observational study from the E3N-EPIC cohort investigated the relationship between various hormone replacement therapy (HRT) regimens and breast cancer risk. The study found that combining estrogens with synthetic progestins increased breast cancer risk, even for short durations, while transdermal estrogens with synthetic progestins also showed an elevated risk. However,
